| Affymax drops as drug trials raise heart concerns - Reuters |
|
|
ReutersThe trials found that safety risks for Hematide were similar to those of current drugs for kidney dialysis patients. The safety of anemia drugs has come ...Affymax's Hematide Data Fall Short Toronto StarAffymax Shares Fall on Drug's Heart Safety Concerns BusinessWeekAmgen's EPO Drugs Dodge a Bullet as Hematide Stumbles, but the Big Biotech's ... read more |